Ke Tan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Acute Kidney Injury

Top Venues

Cell death & disease

Oxidative medicine and cellular longevity

Cell & bioscience

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyu Zhang, Yumei Fan, Ke Tan
A bird's eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications. Cell death & disease 15 (9) (2024)
Jinghan Li, Sujuan Zheng, Yumei Fan, Ke Tan
Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases. Cell death & disease 14 (9) (2023)
Ge Wang, Yumei Fan, Pengxiu Cao, Ke Tan
Insight into the mitochondrial unfolded protein response and cancer: opportunities and challenges. Cell & bioscience 12 (1) (2022)
Danyu Li, Bing Liu, Yumei Fan, Ming Liu, Bihui Han, Yanxiu Meng, Xiao Xu, Zhiyuan Song, Xiaopeng Liu, Qiang Hao, Xianglin Duan, Akira Nakai, Yanzhong Chang, Pengxiu Cao, Ke Tan
Nuciferine protects against folic acid-induced acute kidney injury by inhibiting ferroptosis. British journal of pharmacology 178 (5) (2021)
Fei Chen, Yumei Fan, Pengxiu Cao, Bing Liu, Jiajie Hou, Bo Zhang, Ke Tan
Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy. Oxidative medicine and cellular longevity 2021 (2021)
Ming Liu, Yumei Fan, Danyu Li, Bihui Han, Yanxiu Meng, Fei Chen, Tianchan Liu, Zhiyuan Song, Yu Han, Liying Huang, Yanzhong Chang, Pengxiu Cao, Akira Nakai, Ke Tan
Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Molecular oncology 15 (8) (2021)